The role of the poor metabolizer genotype CYP2D6 and CYP1A2 phenotype in the pharmacokinetics of duloxetine and venlafaxine-A case report.
Maxim KuzinIsabel ScharrerDaniele NolanMarkus BaumgartnerMichael PaulzenGeorgios SchoretsanitisFranziskos XepapadakosPublished in: Basic & clinical pharmacology & toxicology (2020)
Keyphrases